Motherwort for Anxiety and Nervous Tension

Of motherwort's traditional uses, the calming one is the least dramatic and the most defensible. The old European herbals do not separate the heart from the nerves: they describe a single condition in which worry and a gripped, over-revved chest arrive together, and they prescribe motherwort for both at once. Modern pharmacology has not confirmed that picture, but the small amount of animal work that exists points more consistently toward sedation than toward anything else the plant is claimed to do.

This page covers what "nervous tension" meant in the tradition, what the sedative and anxiolytic testing actually shows and in which species, where motherwort sits against better-studied calming herbs, and the practical realities — the bitterness, the sedative additivity, and the fact that anxiety with a physical heart component deserves a look at the heart before it is treated as anxiety.

Table of Contents

1. What "Nervous Tension" Meant
2. The European Calming Tradition
3. Which Species the Anxiety Data Come From
4. Animal Sedative and Anxiolytic Testing
5. The One Human Study, and Why It Is Weak
6. Possible Mechanisms — Honestly Labelled
7. Anxiety, Palpitations, and the Loop Between Them
8. How It Compares to Better-Studied Calming Herbs
9. Sleep, Restlessness, and Evening Use
10. Practical Use, Bitterness, and Dosing Reality
11. When Motherwort Is the Wrong Answer
12. Evidence Tiers at a Glance
13. Key Research Papers
14. Connections

What "Nervous Tension" Meant

The phrase sounds vague to a modern ear, but it described something recognisable. Historical herbalists used it for a cluster of complaints: restlessness, irritability, a mind that would not settle, a sense of internal trembling, difficulty getting to sleep, and — central to motherwort's reputation specifically — a chest that felt tight, gripped, or over-active. The German name Herzgespann catches it exactly: Herz for heart, plus a word family meaning tension or strain, as if something in the chest were stretched taut.

That is not a diagnosis in any current classification, and it maps imperfectly onto what psychiatry now calls generalised anxiety, panic disorder, or somatic symptom disorder. But it maps beautifully onto how patients actually describe themselves in a consulting room. Someone saying "I feel wound up and my heart won't settle" is using the same vocabulary as a seventeenth-century herbal, and that continuity is why the traditional record is worth reading rather than dismissing.

What the tradition does not give us is any way to know whether the herb was doing the work. Pre-modern therapeutics had no controls, no blinding, and every incentive to record successes. Evidence tier: traditional use only.

Back to Table of Contents

The European Calming Tradition

Motherwort's calming role in Europe is old and consistently documented. Nicholas Culpeper's much-quoted line from the mid-seventeenth century — that there is no better herb "to drive melancholy vapours from the heart, to strengthen it, and make the mind cheerful" — is a mood claim as much as a cardiac one, and it is telling that he made both in the same breath. German and Central European herbal traditions used the plant similarly, for a nervous, strained heart and for the agitation that came with it.

In practice it was rarely given alone. Traditional formulation put motherwort alongside other gentle nervines — lemon balm, valerian, passionflower, chamomile, linden — and, where the heart was the focus, alongside hawthorn. Combination is the historical norm, which is worth remembering when a modern single-herb capsule is sold as though it were the traditional article.

The regulatory afterlife of this tradition is instructive. In the European Union, motherwort herb holds status as a traditional herbal medicinal product for the relief of mild, stress-related cardiac symptoms. That category exists precisely because the herb has a long safety record and no adequate trials: registration is granted on the strength of documented traditional use, not demonstrated efficacy. It is a fair and honest label, and it is frequently misrepresented in marketing as an official endorsement of effectiveness. It is not one.

Back to Table of Contents

Which Species the Anxiety Data Come From

Two plants share the name, and the distinction matters as much here as it does for the cardiac claims.

Leonurus cardiaca — the European species — is the one behind the calming tradition, the EU registration, and the small anxiety-relevant studies described below. Nearly every English-language motherwort product means this plant.

Leonurus japonicus — yi mu cao in traditional Chinese medicine — is used mainly gynaecologically in its own tradition rather than as a calming herb, and it is the source of most research on the alkaloid leonurine. Where you see central-nervous-system claims about "motherwort" backed by molecular detail, check whether the constituent is leonurine and the plant japonicus; if so, the finding does not transfer to a European tincture.

The marker alkaloid actually characteristic of L. cardiaca is stachydrine. Direct comparative quantification of stachydrine in both species — reported by Kuchta and colleagues in Fitoterapia in 2014 using quantitative nuclear magnetic resonance — is the reference point for the chemical difference. Alongside stachydrine, L. cardiaca carries iridoid glycosides, a substantial flavonoid fraction (rutin, quercetin, hyperoside and relatives), phenylethanoid glycosides including lavandulifolioside, and the labdane-type diterpene bitters such as leocardin that give the herb its formidable taste.

Back to Table of Contents

Animal Sedative and Anxiolytic Testing

This is the most substantive support the calming claim has, and it is animal work.

Miłkowska-Leyck, Filipek and Strzelecka reported in the Journal of Ethnopharmacology in 2002 on the pharmacological effects of lavandulifolioside isolated from Leonurus cardiaca. Alongside cardiovascular findings — reduced heart rate and lowered blood pressure — they described sedative activity in animal testing. This is a single purified constituent, given to animals, at doses chosen by the investigators; it establishes that something in the plant is capable of a sedative effect, and nothing more. Evidence tier: preclinical (animal), isolated compound.

Koshovyi and colleagues published in Plants in 2021 on the phytochemical and psychotropic properties of modified dry extracts of Leonurus cardiaca, pairing chemical characterisation of the extracts with animal behavioural testing for sedative and anxiolytic-type activity. This is closer to a real product — a whole-herb dry extract rather than an isolate — and it reported behavioural effects consistent with the traditional calming use. It remains animal behavioural work, and behavioural paradigms in rodents are notoriously imperfect proxies for human anxiety. Evidence tier: preclinical (animal), whole extract.

Rezaee-Asl and colleagues reported in 2014, in International Scholarly Research Notices, on analgesic effects of Leonurus cardiaca in mice using formalin, tail-flick and hot-plate tests. Analgesia is not anxiolysis, but pain-behaviour testing is sensitive to sedation, and the result belongs in the same general picture of central depressant activity. Evidence tier: preclinical (animal).

What all of this adds up to is a coherent preclinical signal for central calming activity in L. cardiaca. What it does not add up to is a demonstrated effect in a person. The step from a purified glycoside in a rodent to a few millilitres of tincture in a human being spans absorption, metabolism, dose, and the fact that no one has measured whether the relevant compounds reach the brain at meaningful concentrations after oral dosing.

Back to Table of Contents

The One Human Study, and Why It Is Weak

The only human evidence bearing on anxiety is a single report: Shikov and colleagues in Phytotherapy Research in 2011, evaluating a Leonurus cardiaca oil extract in patients with arterial hypertension accompanied by anxiety and sleep disorders. Participants numbered in the dozens. Anxiety and depression scores improved and blood pressure fell modestly.

Three problems, and they are decisive rather than pedantic.

1. No placebo group. Subjective anxiety scores are among the most placebo-responsive outcomes in all of clinical research. Trials of anxiolytic drugs routinely see substantial improvement in the placebo arm. Without one, an uncontrolled improvement is uninterpretable — it is entirely consistent with the herb doing nothing.
2. Small size and open label. Both participants and investigators knew what was being given. Expectation shapes self-reported anxiety powerfully, and it shapes what an unblinded assessor records.
3. Not replicated. Fifteen years on, no adequately powered randomized controlled trial has confirmed it. In a field where a positive uncontrolled result would be easy and cheap to follow up, that absence is itself information.

Both major reviews reach the same conclusion. Wojtyniak, Szymański and Matławska's 2013 review in Phytotherapy Research and Fierascu and colleagues' 2019 update in BioMed Research International — the latter written explicitly against the European Medicines Agency's assessment — describe a plant with a rich traditional record, a reasonable preclinical base, and no adequate clinical trial evidence for any indication. Randomized clinical trial evidence for motherwort in anxiety: none.

Back to Table of Contents

Possible Mechanisms — Honestly Labelled

Because nobody has shown a clinical effect, mechanism here is speculation constrained by what has been measured. Setting out the candidates makes clear how much is unknown.

• Direct central sedation. The animal sedative findings for lavandulifolioside and for whole dry extracts are consistent with central depressant activity, but the receptor target has not been established. Motherwort is often loosely grouped with GABAergic calming herbs; for L. cardiaca specifically, that grouping is an assumption, not a finding. Contrast passionflower, where the GABA hypothesis has actually been investigated.
• Peripheral dampening of the anxiety loop. This is the most interesting possibility and the least discussed. If the herb genuinely blunts heart rate a little, it could reduce the palpitation sensations that feed anxiety — treating the physical limb of the loop rather than the mental one. Mechanistically the same logic underlies prescribing a beta-blocker for performance anxiety. Plausible, untested in humans.
• Bitter-mediated effects. Intense bitterness has real physiology attached — vagal and digestive responses — and traditional herbalism attached considerable importance to it. As an explanation for calming it is thin, but it is not nothing.
• Flavonoid activity. The flavonoid fraction is substantial and flavonoids have documented central effects in animal models, but no L. cardiaca flavonoid has been tied to an anxiolytic outcome in a person.
• Nonspecific effects. Preparing and drinking a hot infusion, or performing a deliberate self-care ritual twice a day, has measurable effects on subjective anxiety independent of pharmacology. This is not a dismissal — it is a real effect — but it is not evidence about the plant.

Back to Table of Contents

Anxiety, Palpitations, and the Loop Between Them

Motherwort sits at a specific intersection, and the intersection is where the clinical care needs to be taken.

The loop is familiar to anyone who has lived it. A physical sensation arrives — a thump, a flutter, an awareness of the pulse. Attention locks onto it. Attention drives adrenaline, adrenaline raises heart rate and force of contraction, and the sensation intensifies, which confirms the alarm. People in this loop are often described as having "just anxiety," and they can go years without either the anxiety or the heart being properly addressed.

Two errors are possible here and they run in opposite directions.

Error one: treating a rhythm problem as anxiety. Supraventricular tachycardia in particular is frequently misattributed to panic, because it starts abruptly, produces a pounding fast heartbeat and a sense of doom, and stops as suddenly as it started. It is also curable. An overactive thyroid can present as pure anxiety with palpitations and tremor. Low potassium or magnesium can produce both palpitations and jitteriness. If your palpitations have never been recorded on an ECG, that is the missing step — see Motherwort for Palpitations and Heart Complaints for the red-flag list, and Supraventricular Tachycardia, Hyperthyroidism and Anemia for the common mimics.

Error two: treating anxiety as a rhythm problem. Once the workup is clean, continuing to search for a cardiac cause maintains the loop. This is where the traditional target of motherwort — the nervous, strained heart in a structurally normal chest — genuinely lives. It is also where effective anxiety treatment, including cognitive behavioural approaches, has real evidence behind it in a way no herb does.

The honest sequence is therefore: get the rhythm characterised, then treat the anxiety with the things that work, and consider a mild calming herb as an adjunct if you want one.

Back to Table of Contents

How It Compares to Better-Studied Calming Herbs

If your goal is a calming herb and you are choosing on evidence, motherwort is not the strongest candidate. Being candid about that is more useful than advocacy.

• Passionflower has been examined in small randomized trials for anxiety, including preoperative anxiety, and has an investigated GABAergic hypothesis. More human data than motherwort.
• Lemon balm has small controlled human studies on mood and stress measures and a far more agreeable taste — a genuinely relevant advantage for a herb you must take repeatedly.
• Valerian has a substantial if inconsistent trial literature, mostly on sleep.
• Ashwagandha has the largest number of randomized trials of any herb commonly used for stress, though quality and independence vary and it acts differently.
• Chamomile has been studied in generalised anxiety disorder in at least one controlled trial.
• L-Theanine has human data on stress measures and is not a herb at all, but belongs on any honest shortlist.
• Magnesium matters if you are actually deficient, and deficiency plausibly contributes to both anxiety and palpitations — a rare case where correcting a measurable deficit is the right move rather than a botanical.

Motherwort's distinctive claim is not potency; it is the combination of a calming effect with a cardiac tradition. If the thing bothering you is specifically an anxious awareness of your heartbeat, that combination is the reason to consider it. If you simply want to feel less anxious, better-studied options exist.

Back to Table of Contents

Sleep, Restlessness, and Evening Use

Traditional use included restlessness and difficulty settling at night, and the one human study enrolled people with sleep disturbance alongside anxiety and hypertension — though it was not a sleep trial and cannot support a sleep claim.

The animal sedative findings make evening dosing a sensible default if you use the herb at all: any drowsiness lands when you want it rather than mid-afternoon. The corresponding risk is additive sedation, which matters more than people expect. Combining motherwort with a prescribed sleep medicine, a benzodiazepine, a sedating antihistamine, alcohol, or another sedative herb such as valerian can produce more drowsiness than any of them alone. Take care with driving and machinery. For evidence-based approaches to sleep, Insomnia is the better starting point, and cognitive behavioural therapy for insomnia outperforms every herb studied.

Back to Table of Contents

Practical Use, Bitterness, and Dosing Reality

The part used is the aerial part — leafy flowering tops. Standardised dosing does not exist for this herb, and honest guidance has to say so.

• Infusion. Traditionally one to two grams of dried herb per cup, steeped covered. The taste is the obstacle. Motherwort is one of the most bitter herbs in common use, and the diterpene bitters responsible for it are not maskable by a little honey. Many people abandon the tea within days.
• Tincture. The usual modern form, taken as drops in a small amount of water, precisely because it compresses the bitterness into a swallow. Follow the product's own directions — concentrations differ several-fold between manufacturers. Note the alcohol content if that matters to you.
• Capsules. Tasteless and convenient; the dose is whatever the manufacturer chose, and you get no sensory check on the material's quality.
• Combination products. Very common, and closer to traditional practice — but they make it impossible to know what is doing what, and they multiply the interaction surface.

Two quality points specific to this plant. First, name the species: buy from a supplier whose label says Leonurus cardiaca, because substitution with japonicus occurs in the global trade. Second, start low. The bitterness can produce nausea, stomach discomfort or loose stools, particularly at higher doses, and that is the most common reason people stop.

Back to Table of Contents

When Motherwort Is the Wrong Answer

• Pregnancy — a firm contraindication. The name misleads badly here. Motherwort is a traditional uterine stimulant and emmenagogue and should be avoided in pregnancy. Anxiety in pregnancy is common and treatable; this is not the treatment. See the safety page.
• Breastfeeding — avoid, for lack of data.
• On cardiac or blood-pressure medication — beta-blockers, other rate-slowing drugs, antihypertensives, digoxin, antiarrhythmics. Do not add it without your prescriber's input.
• On sedatives or alcohol — additive drowsiness is the best-supported interaction the herb has.
• On anticoagulants or antiplatelet drugs — theoretical bleeding caution.
• Severe or worsening anxiety, panic attacks, or any thoughts of self-harm. This needs proper care now, not a tincture. Panic Disorder is specifically and effectively treatable.
• Uncharacterised palpitations — get the rhythm recorded first.

Back to Table of Contents

Evidence Tiers at a Glance

• Traditional use only — motherwort for nervous tension, restlessness, irritability and the anxious "strained heart." Centuries of European use; the basis of the EU traditional-use registration.
• Preclinical (animal, isolated compound) — lavandulifolioside from L. cardiaca showed sedative activity alongside reduced heart rate and blood pressure (Miłkowska-Leyck and colleagues, 2002).
• Preclinical (animal, whole extract) — modified dry extracts of L. cardiaca showed psychotropic activity in behavioural testing (Koshovyi and colleagues, 2021); analgesic testing in mice consistent with central depressant activity (Rezaee-Asl and colleagues, 2014).
• Preliminary human, uncontrolled — one small open-label oil-extract study reported improved anxiety and depression scores in hypertension with sleep disturbance (Shikov and colleagues, 2011). No placebo arm; not replicated.
• Randomized clinical trial evidence — none for anxiety, sleep, or stress.

Back to Table of Contents

Key Research Papers

Links are PubMed topic searches, so they keep returning the current literature rather than one frozen record.

1. Miłkowska-Leyck K, Filipek B, Strzelecka H. Pharmacological effects of lavandulifolioside from Leonurus cardiaca. Journal of Ethnopharmacology, 2002. The core sedative finding for a cardiaca constituent, alongside reduced heart rate and blood pressure in animals. PubMed: lavandulifolioside Leonurus cardiaca sedative
2. Koshovyi O, Raal A, Kireyev I, et al. Phytochemical and psychotropic research of motherwort (Leonurus cardiaca L.) modified dry extracts. Plants, 2021. Whole-extract chemistry paired with animal behavioural testing. PubMed: Leonurus cardiaca psychotropic dry extracts
3. Shikov AN, Pozharitskaya ON, Makarov VG, et al. Effect of Leonurus cardiaca oil extract in patients with arterial hypertension accompanied by anxiety and sleep disorders. Phytotherapy Research, 2011. The only human anxiety-relevant report; small, open-label, no placebo group. PubMed: Leonurus cardiaca anxiety and sleep
4. Rezaee-Asl M, Sabour M, Nikoui V, et al. The study of analgesic effects of Leonurus cardiaca L. in mice by formalin, tail flick and hot plate tests. International Scholarly Research Notices, 2014. Animal pain-behaviour work bearing on central depressant activity. PubMed: Leonurus cardiaca analgesic mice
5. Wojtyniak K, Szymański M, Matławska I. Leonurus cardiaca L. (motherwort): a review of its phytochemistry and pharmacology. Phytotherapy Research, 2013. The standard review; reaches the same conclusion about the absence of trials. PubMed: Leonurus cardiaca review
6. Fierascu RC, Fierascu I, Ortan A, et al. Leonurus cardiaca L. as a source of bioactive compounds: an update of the European Medicines Agency assessment report. BioMed Research International, 2019. Chemistry and pharmacology set against Europe's formal regulatory assessment. PubMed: Leonurus cardiaca EMA assessment update
7. Kuchta K, Ortwein J, Hennig L, et al. Direct quantification of stachydrine in Leonurus japonicus and L. cardiaca by quantitative nuclear magnetic resonance. Fitoterapia, 2014. Establishes the chemical boundary between the two species. PubMed: stachydrine in Leonurus species
8. Agnihotri VK, ElSohly HN, Smillie TJ, et al. New labdane diterpenes from Leonurus cardiaca. Planta Medica, 2008. The bitter diterpene constituents responsible for the taste. PubMed: labdane diterpenes Leonurus cardiaca
9. Ritter M, Melichar K, Strahler S, et al. Cardiac and electrophysiological effects of primary and refined extracts from Leonurus cardiaca L. Planta Medica, 2010. Relevant here because the peripheral heart-rate effect is one candidate route to feeling calmer. PubMed: Leonurus cardiaca heart rate effects
10. Reviews of Leonurus japonicus traditional uses, phytochemistry and pharmacology. Cited to keep the species boundary explicit; most leonurine work sits here, not in the European plant. PubMed: Leonurus japonicus review
11. Comparative literature on herbal anxiolytics — passionflower, lemon balm, valerian and chamomile in controlled human trials — which is the fair benchmark against which motherwort's evidence should be judged. PubMed: herbal anxiolytics randomized trials
12. Broader current searches: PubMed: motherwort anxiety and PubMed: Leonurus cardiaca sedative anxiolytic.

External Resources

• NCCIH — US National Center for Complementary and Integrative Health; herb-by-herb evidence summaries.
• MedlinePlus — consumer health information from the US National Library of Medicine.
• European Medicines Agency — publishes the herbal monograph and assessment report underlying motherwort's EU traditional-use status.
• NHS (United Kingdom) — plain-language information on anxiety and on when palpitations need urgent assessment.
• National Institute of Mental Health — evidence-based information on anxiety disorders and their treatment.

Back to Table of Contents

Connections

• All Herbs
• Motherwort
• Motherwort Benefits Hub
• Motherwort for Palpitations
• Motherwort Safety
• Anxiety
• Panic Disorder
• Insomnia
• Palpitations
• Supraventricular Tachycardia
• Hyperthyroidism
• Passionflower for Anxiety
• Passionflower and GABA
• Lemon Balm for Anxiety
• Valerian for Anxiety
• Chamomile
• Lavender
• Skullcap
• Ashwagandha
• L-Theanine
• Magnesium, Anxiety and Insomnia
• Hawthorn, Anxiety and Mood

Safety Note and Disclaimer

This page is health education, not medical advice. Motherwort's calming use rests on centuries of European tradition plus animal sedative studies and a single small uncontrolled human report; there is no randomized controlled trial evidence that it treats anxiety, stress or insomnia. It is not a substitute for treatment of an anxiety disorder, and severe anxiety, panic attacks, or any thoughts of self-harm need prompt professional care. Motherwort can add to the effects of sedatives, sleep medicines, alcohol and other calming herbs, and may add to the effects of beta-blockers, other rate-slowing and blood-pressure drugs, digoxin, antiarrhythmics, antiplatelet drugs and anticoagulants — check with your doctor or pharmacist before combining. It should be avoided in pregnancy and, for lack of data, while breastfeeding. Palpitations that have never been evaluated need an ECG rather than a herb.

Back to Table of Contents